Kronos Bio • KRON
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Professor Dr. Norbert W. Bischofberger, PhD$62.2M
Market Cap • 17/04/20242017
(há 7 anos)
2020
(4 years ago)
NASDAQ
Listagem
San Mateo
Sede • California97
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
KRONSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.